[HTML][HTML] Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants

PP Bocchino, F Angelini, E Toso - Reviews in Cardiovascular …, 2021 - imrpress.com
Atrial fibrillation (AF) represents the most prevalent supraventricular arrhythmia in adults
population and up to 15% of AF patients undergo percutaneous coronary intervention (PCI) …

Selected aspects of the state of the art in biomaterials for cardiovascular applications

TA Horbett - Colloids and Surfaces B: Biointerfaces, 2020 - Elsevier
A review of selected aspects of biomaterials used for cardiovascular applications is
presented in honor of the long-term editorship of John Brash of the journal Colloids and …

[HTML][HTML] Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based …

J Harris, KB Pouwels, T Johnson, J Sterne… - Health Technology …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Bleeding among populations undergoing percutaneous coronary
intervention or coronary artery bypass grafting and among conservatively managed patients …

Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

M Casula, F Fortuni, M Ferlini, F Fabris… - American Journal of …, 2021 - Springer
Background In patients with atrial fibrillation (AF) receiving percutaneous coronary
intervention (PCI), current guidelines recommend against combining potent oral P2Y 12 …

Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis

F Angelini, F Fortuni, G Tsivgoulis, G Agnelli… - … Drugs and Therapy, 2021 - Springer
Purpose Patients with patent foramen ovale (PFO) and cryptogenic ischemic stroke (CS) are
at risk for stroke recurrence. The optimal antithrombotic strategy in patients who undergo …

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

H Han, H Xu, J Zhang, W Zhang, Y Yang… - Frontiers in …, 2025 - frontiersin.org
Background Patients with comorbid coronary artery disease and valvular heart disease
usually undergo coronary artery bypass grafting alongside valve replacement or ring repair …

Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis

M Casula, F Fortuni, F Fabris, S Leonardi… - Journal of …, 2020 - journals.lww.com
Aims Patients with cancer are at higher risk of atrial fibrillation, thromboembolic
complications and bleeding events compared with the general population. The aim of the …

Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence

E Ricottini, A Nenna, R Melfi, S Giannone… - European journal of …, 2020 - Elsevier
Background The management of antithrombotic therapy in patients undergoing
percutaneous coronary intervention (PCI) with an indication for long-term oral anticoagulant …

Finding the right balance

A Goedel, N Sarafoff - International …, 2018 - internationaljournalofcardiology.com
Patients with an indication for oral anticoagulation (OAC) that receive antiplatelet therapy
after percutaneous coronary intervention (PCI) are challenging for the treating physician. It is …

[HTML][HTML] Evidence review for antiplatelet therapy for people with an ongoing separate indication for anticoagulation

NGC UK - 2020 - ncbi.nlm.nih.gov
Evidence review for antiplatelet therapy for people with an ongoing separate indication for
anticoagulation - NCBI Bookshelf US flag An official website of the United States government …